The MajesTEC-1 trial (NCT04557098) 1,2 focusing on the bispecific antibody teclistamab (Tecvayli), stands as a landmark study in this space. Conducted during the unique logistical and clinical ...

"I would not be stood here today if not for this treatment" ...

Health officials are warning that confirmed cases of measles may have spread at this year's National March for Life rally and concert in Washington, D.C. Thousands of anti-abortion demonstrators ...

WASHINGTON — Health officials are investigating after multiple people with measles cases were confirmed to have visited locations throughout the District. The infections sites included the National ...

DC Health said Saturday it was notified of multiple people with confirmed cases of measles who visited a variety of locations in the District. Officials did not specify exactly how many infected ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Caring for someone with multiple myeloma can be challenging on many levels. The person who has just been diagnosed may look to you for information to help them better understand the disease to ...

Targeted therapies, bispecifics, and CAR T-cell therapies are giving patients with multiple myeloma hope for long-term remission or a potential cure. He expanded on this topic during the panel, ...

Biologic heterogeneity in myeloma supports subtype-specific approaches, and t(4;14) defines a clinically meaningful subset with distinct pathway activation and historically aggressive behavior.

The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of ...

Life expectancy was 79.0 years for the US population in 2024, marking a 0.6-year increase from 2023. HealthDay News — From 2023 to 2024, there was an increase in life expectancy and a decrease in ...